GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krka d.d. (WAR:KRK) » Definitions » Stock Based Compensation

Krka d.d. (WAR:KRK) Stock Based Compensation : zł0 Mil (TTM As of Sep. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Krka d.d. Stock Based Compensation?

Krka d.d.'s Stock Based Compensation for the three months ended in Sep. 2023 was zł0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2023 was zł0 Mil.


Krka d.d. Stock Based Compensation Historical Data

The historical data trend for Krka d.d.'s Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krka d.d. Stock Based Compensation Chart

Krka d.d. Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Krka d.d. Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Krka d.d. Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0 Mil.


Krka d.d. Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Krka d.d.'s Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Krka d.d. (WAR:KRK) Business Description

Traded in Other Exchanges
Address
Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka d.d. engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resort, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, Oncology; Non-prescription products include Cold and cough products, nasal products, vitamin and minerals, hair care products; and Animal health products include Antimicrobials, Disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of revenue from the European Union.

Krka d.d. (WAR:KRK) Headlines

No Headlines